DLEU2 and colorectal carcinoma: Results of the CCK-8 assay showed that LINC00022 overexpression obviously increased the viability of CRC cells compared with the Lv-NC group (1.3–1.4 fold), whereas LINC00022 silencing decreased cell viability (0.6–0.7 fold) compared with the Lv-anti-NC group (Fig. 2b).